With regard to testing for SARS-CoV-2: (a) for each month since March, 2020, (i) what SARS-CoV-2 testing devices were approved, including the name, manufacturer, device type, whether the testing device is intended for laboratory or point-of-care use, and the date authorized, (ii) what was the length in days between the submission for authorization and the final authorization for each device; (b) for each month since March, how many Cepheid Xpert Xpress SARS-CoV-2 have been (i) procured, (ii) deployed across Canada; (c) for what testing devices has the Minister of Health issued an authorization for importation and sale under the authority of the interim order respecting the importation and sale of medical devices for use in relation to COVID-19; (d) for each testing device so authorized, which ones, as outlined in section 4(3) of the interim order, provided the minister with information demonstrating that the sale of the COVID-19 medical device was authorized by a foreign regulatory authority; and (e) of the antigen point-of-care testing devices currently being reviewed by Health Canada, which are intended for direct purchase or use by a consumer at home?
In the House of Commons on November 16th, 2020. See this statement in context.